Impacto de la inclusión de pruebas de segundo nivel en el programa de cribado neonatal de Cataluña y en otros programas internacionales

Pajares García, Sonia; López Galera, Rosa M; Marín Soria, Jose Luis; Argudo Ramírez, Ana; González de Aledo-Castillo, Jose Manuel; Ribes Rubió, Antonia; Prats Viedma, Blanca; Asso Ministral, Laia; García-Villoria, Judit.
Rev. esp. salud pública ; 94: 0-0, 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-200463

Documentos relacionados

  1. Severe combined immunodeficiency diagnosis and genetic defects.
  2. Clinical, immunological and molecular findings of 8 patients with typical and atypical severe combined immunodeficiency: identification of 7 novel mutations by whole exome sequencing.
  3. Human Autosomal Recessive DNA Polymerase Delta 3 Deficiency Presenting as Omenn Syndrome.
  4. [CLINICAL CASE OF SEVERE COMBINED IMMUNE DEFICIENCY].
  5. A novel homozygous <i>RAG1</i> mutation is associated with severe combined immunodeficiency and neurological presentations.
  6. Severe combined immunodeficiencies: Expanding the mutation spectrum in Turkey and identification of 12 novel variants.
  7. Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.
  8. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
  9. Impact of newborn screening for SCID on the management of congenital athymia.
  10. Transplantation to save the life, TSH screening to save the brain: A report and brief literature review of autoimmune thyroid disease after HSCT for severe combined immunodeficiency.